메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 21, Issue 11, 2003, Pages 2223-
Guidelines for the use of epoetin: Have quality-of-life benefits been proven?
Author keywords

[No Author keywords available]
Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;
EID: 0037530495     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.99.208     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 0036787775 scopus 로고    scopus 로고
    • Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
    • Rizzo JD, Lichtin AE, Woolf SH, et al: Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20:4083-4107, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 4083-4107
    • Rizzo, J.D.1    Lichtin, A.E.2    Woolf, S.H.3
  • 2
    • 0034856819 scopus 로고    scopus 로고
    • Cancer therapy: New strategies and treatment modalities for optimizing patient outcomes
    • Gabrilove JL: Cancer therapy: New strategies and treatment modalities for optimizing patient outcomes. Semin Hematol 38:1-7, 2001 (suppl 7)
    • (2001) Semin Hematol , vol.38 , pp. 1-7
    • Gabrilove, J.L.1
  • 3
    • 0036521691 scopus 로고    scopus 로고
    • Human recombinant erythropoietin and quality of life: A wonder drug or something to wonder about?
    • Bottomley A, Thomas R, Van Steen K, et al: Human recombinant erythropoietin and quality of life: A wonder drug or something to wonder about? Lancet Oncol 3:145-153, 2002
    • (2002) Lancet Oncol , vol.3 , pp. 145-153
    • Bottomley, A.1    Thomas, R.2    Van Steen, K.3
  • 4
    • 0035367087 scopus 로고    scopus 로고
    • Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebocontrolled trial
    • Littlewood TJ, Bajetta E, Nortier JW, et al: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebocontrolled trial. J Clin Oncol 19:2865-2874, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 2865-2874
    • Littlewood, T.J.1    Bajetta, E.2    Nortier, J.W.3
  • 5
    • 0036076066 scopus 로고    scopus 로고
    • Quality of life in oncology clinical trials: Present and future challenges
    • Bottomley A, Flechtner H: Quality of life in oncology clinical trials: Present and future challenges. Expert Rev Pharmacoeconomics Outcomes Res 2:67-76, 2002
    • (2002) Expert Rev Pharmacoeconomics Outcomes Res , vol.2 , pp. 67-76
    • Bottomley, A.1    Flechtner, H.2
  • 6
    • 0037068634 scopus 로고    scopus 로고
    • Quality of life after radical prostatectomy or watchful waiting
    • Steineck G, Helgesen F, Adolfsson J, et al: Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347:790-796, 2002
    • (2002) N Engl J Med , vol.347 , pp. 790-796
    • Steineck, G.1    Helgesen, F.2    Adolfsson, J.3
  • 7
    • 8944220720 scopus 로고    scopus 로고
    • Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormoneresistant prostate cancer: A Canadian randomized trial with palliative end points
    • Tannock IF, Osoba D, Stockler MR, et al: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormoneresistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 14:1756-1764, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 1756-1764
    • Tannock, I.F.1    Osoba, D.2    Stockler, M.R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.